Come up with a name for your new list and we'll add to it:
EncephRX raised a round of funding on July 08, 2011. Investors include
Maryland Technology Development Corporation.
EncephRX is developing a small molecule platform for treatment of neurodegenerative diseases such as Huntington's, Parkinson's and Alzheimer's disease. This platform will provide a first-in-class ther…